Muhammad Mahdi Nashatizadeh

Muhammad Mahdi Nashatizadeh, M.D. serves as Clinical Associate Professor in the Department of Neurology at the University of Kansas School of Medicine, where he directs the Inpatient Movement Disorders program and leads the academic neurology consultation service. His clinical work integrates neurological care across emergency medicine, internal medicine, rehabilitation, and surgical services for hospitalized patients with complex neurological conditions.

His educational journey includes a Biology BS with University Scholar honors from Emporia State University (1998), an MD from the University of Kansas School of Medicine (2003), internal medicine internship (2004), neurology residency (2007), and movement disorders fellowship at Baylor College of Medicine (2008). He maintains board certification in neurology through the American Board of Psychiatry and Neurology and holds medical licenses in Kansas and Missouri.

Dr. Nashatizadeh's research centers on atypical parkinsonism mechanisms, movement-cognitive disorder interactions, and novel therapeutics for debilitating movement disorders. His publication record (2008-2020) reveals concentrated expertise in Parkinson's disease therapeutics, tremor pathophysiology, deep brain stimulation applications, and disability assessment metrics, with significant emphasis on translating clinical observations into practical interventions for complex neurological presentations.

His scientific contributions have been recognized through:

• Top five finalist for the prestigious Rainbow Award (2018-2019)
• Neurology Attending Educator of the Year (Student Voice Award) for five consecutive years (2017-2021)

As an educator, he trains geriatrics fellows, neurology/internal medicine/psychiatry residents, and medical students, emphasizing neurological manifestations of systemic diseases and multi-layered neurological diagnoses in acute care. His professional engagement includes active membership in the Movement Disorder Society (2006-present), American Academy of Neurology (2004-present), and Kansas City Clinical Neuroscience Society (2016-present), reflecting sustained commitment to advancing neurological care and education.